🔎 Trials Near Me

Home › Stomach Cancer › Texas › San Antonio

Stomach Cancer clinical trials in San Antonio, TX

19 studies for Stomach Cancer are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Audie L Murphy VA Hospital, San Antonio
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

RecruitingPhase 1
  • NEXT Oncology - PARENT, San Antonio
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07360314

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecruitingPhase 1/2
  • NEXT Oncology San Antonio, San Antonio
  • START Texas, San Antonio
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

RecruitingPhase 1
  • NEXT Oncology, San Antonio
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07705334

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

RecruitingPhase 1/2
  • START South Texas Accelerated Research Therapeutics, San Antonio
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05267626

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

RecruitingPhase 1
  • START - San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06293898

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

RecruitingPhase 1/2
  • South Texas Accelerated Research Therapeutics (START), LLC, San Antonio
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT07070232

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

RecruitingPhase 1
  • NEXT San Antonio, San Antonio
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT07227168

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2
  • Research Site, San Antonio
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07115043

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • UT Health Mays Cancer Center, San Antonio
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • Clinical Trial Site, San Antonio
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07749586

IDOV-Immune for Advanced Solid Tumors

RecruitingPhase 1
  • South Texas Accelerated Research Therapeutics, San Antonio
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT06910657

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

RecruitingPhase 1
  • NEXT Virginia, LLC, San Antonio
  • South Texas Accelerated Research Therapeutics, LLC, San Antonio
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT05208762

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

RecruitingPhase 1
  • South Texas Accelerated Research Therapeutics, LLC, San Antonio
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT06131840

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

RecruitingPhase 1
  • START San Antonio, LLC., San Antonio
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT06657144

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

RecruitingPhase 1
  • NEXT Oncology /ID# 243007, San Antonio
  • South Texas Accelerated Research Therapeutics (START) /ID# 276268, San Antonio
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT05005403

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

RecruitingPhase 1/2
  • NEXT Oncology, San Antonio
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06239194

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

RecruitingPhase 1
  • Dren Investigational Site, San Antonio
Ages 18 and older · All sexes · Updated Jan 7, 2026 · NCT06999187

About Stomach Cancer

Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.

More about Stomach Cancer on MedlinePlus

Stomach Cancer trials in other cities

Other studies in San Antonio

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.